evitria is specialized in CHO-based transient expression of antibodies (including bispecific and fusion antibodies). With a track record of more than 50,000 transfections performed and more than 9,000 antibodies expressed and purified for our clients, we can offer fast and reliable project execution at high quality standards (all production facilities in Switzerland) and affordable prices. Transfections are made with serum-free, animal-component free reagents at a monthly capacity of up to 500 liters.
You can benefit from our expertise and unique focus when looking to entrust a partner with your complete antibody production or to manage capacity bottlenecks with single projects.
Location: Switzerland, Zurich, Schlieren
Employees: 11-50
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | SHS Gesell... | shs-capita... |
Mentions in press and media 6
| Date | Title | Description | Source |
| 20.02.2024 | Dr. Desmond Schofield new CBO of evitria | As of January 2024, Dr. Desmond Schofield has become new CBO at evitria AG. As of January 2024, Dr. ... | einpresswi... |
| 03.12.2023 | Antibody Production Companies: Re-shaping Life Sciences Toge... | Carl Williams, Tech Times 03 December 2023, 08:12 pm (Photo : Michal Jarmoluk from Pixabay) Antibody... | techtimes.... |
| 10.07.2023 | Diagnostic antibodies – evolution of medical diagnostics | Diagnostic methods in the course of time, along with four approaches in today's diagnostics. BOSTON,... | einpresswi... |
| 03.05.2023 | Dr. Stefan Schmidt new CEO of evitria | Dr. Stefan Schmidt – new CEO at evitria | © Atlas Antibodies ZURICH, SWITZERLAND, May 3, 2023/EINPre... | einpresswi... |
| 03.08.2021 | Atlas Antibodies acquires biotech service provider evitria | Since its inception in 2010, evitria is a biotech service provider focused on the transient expressi... | startuptic... |
| 21.12.2018 | Biotech service provider evitria backed by two new investors | startuptic... |